ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BOLT Bolt Biotherapeutics Inc

0.80
0.0255 (3.29%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 562,369
Bid Price 0.7701
Ask Price 0.79
News -
Day High 0.81

Low
0.7341

52 Week Range

High
1.935

Day Low 0.77
Share Name Share Symbol Market Stock Type
Bolt Biotherapeutics Inc BOLT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0255 3.29% 0.80 17:55:36
Open Price Low Price High Price Close Price Previous Close
0.7777 0.77 0.81 0.79 0.7745
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
554 562,369 US$ 0.7921694 US$ 445,492 - 0.7341 - 1.935
Last Trade Type Quantity Price Currency
18:40:57 10 US$ 0.7727 USD

Bolt Biotherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
29.61M 37.97M - 7.88M -69.2M -1.82 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Bolt Biotherapeutics News

Date Time Source News Article
5/20/202412:22Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
5/15/202416:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
5/14/202415:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202415:06Edgar (US Regulatory)Form 8-K - Current report
5/14/202415:05GlobeNewswire Inc.Bolt Biotherapeutics Reports First Quarter 2024 Results,..
3/21/202415:05GlobeNewswire Inc.Bolt Biotherapeutics Reports Fourth Quarter and Full-Year..
3/06/202412:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202412:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/27/202406:00GlobeNewswire Inc.Bolt Biotherapeutics to Present at the TD Cowen 44th Annual..
2/12/202420:41Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
2/06/202412:09Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership..
12/21/202306:30GlobeNewswire Inc.Pacira Appoints Frank D. Lee as Chief Executive Officer
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BOLT Message Board. Create One! See More Posts on BOLT Message Board See More Message Board Posts

Historical BOLT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.8450.8450.73410.7802482477,115-0.045-5.33%
1 Month1.161.3350.73410.8828795413,243-0.36-31.03%
3 Months1.141.560.73411.04235,684-0.34-29.82%
6 Months0.93321.560.73411.05174,612-0.1332-14.27%
1 Year1.931.9350.73411.12140,722-1.13-58.55%
3 Years18.7619.2850.73414.05208,351-17.96-95.74%
5 Years26.1043.070.73417.34215,956-25.30-96.93%

Bolt Biotherapeutics Description

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

Your Recent History

Delayed Upgrade Clock